FALLOPIAN TUBE CANCER

This is the first human study testing the safety and early effects of an experimental drug called BL-M17D1 in people with advanced cancers that have a specific marker called HER2. The trial will enroll 120 adults with various hard-to-treat cancers, including breast, lung, and sto…

This early-stage study is testing a new drug called IMGN151 in patients with recurrent gynecologic cancers that have returned after previous treatments. The main goals are to determine the safest dose, understand how the drug behaves in the body, and see if it shows any early sig…

This study is testing whether the drug bevacizumab (Avastin) can help control ovarian, fallopian tube, or primary peritoneal cancer that was discovered during a second surgery after initial treatment. The research involves 35 participants who have completed standard chemotherapy …

This study is testing a two-part treatment for ovarian cancer that has come back after initial chemotherapy. It combines a standard chemotherapy drug with a newer, targeted drug designed to attack cancer cells with a specific marker. After the combination phase, patients continue…

This study aimed to test a new targeted drug called BAT8006 for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to standard platinum-based chemotherapy. The two-part trial planned to first find a safe and effective dose, then …

This study is testing if a simple electronic reminder for doctors can help more patients with a suspicious ovarian mass get quickly referred to a specialized cancer surgeon. The goal is to see if this 'nudge' improves the speed and rate of referrals, especially for patients from …

This study is testing whether adding a new experimental drug called IMNN-001 to standard chemotherapy before surgery can better control advanced ovarian, fallopian tube, or primary peritoneal cancer. The drug is designed to stimulate the immune system and is delivered directly in…

This study is testing whether a three-drug combination can help the body's immune system fight advanced ovarian, fallopian tube, or primary peritoneal cancer that has returned after initial treatment. The treatment includes an immunotherapy drug (pembrolizumab), an investigationa…

This study aims to find the best dose of a new oral drug called sovilnesib for people with advanced ovarian cancer that has stopped responding to standard platinum-based chemotherapy. About 120 participants will take different doses to see which one is safest and shows the most p…

This study is testing whether two immunotherapy drugs, nivolumab alone or combined with ipilimumab, can help control recurrent clear cell ovarian, fallopian tube, and related cancers. It will enroll 46 patients whose cancer has returned after standard chemotherapy. The main goal …

This large, late-stage study is testing whether adding two newer drugs—an immunotherapy (pembrolizumab) and a maintenance therapy (olaparib)—to standard chemotherapy can help women with advanced ovarian, fallopian tube, or peritoneal cancer live longer without their cancer gettin…

This small pilot study is testing whether a special support program is practical and helpful for women with advanced ovarian cancer. The program includes exercise, nutrition, and stress management, and is given alongside chemotherapy before major surgery. The goal is to see if th…

This study is testing an online program called 'Journey Ahead' designed to help women with gynecologic cancers (like ovarian, cervical, or uterine cancer) develop better coping and communication skills. The program aims to reduce distress, improve emotional acceptance, and enhanc…

This study aims to find a quick way to spot depression in women with ovarian, peritoneal, or fallopian tube cancer. It also compares a 10-week phone counseling program with standard care to see which better improves patients' quality of life. Participants answer questionnaires an…

This small, early-stage study is exploring whether taking low-dose aspirin for two weeks before surgery can reduce inflammation in the fallopian tubes. It involves 18 women who are already scheduled to have their fallopian tubes removed for non-cancer reasons. The main goal is to…

This study is observing 100 women with breast or gynecological cancers to see if their diet in the month before starting chemotherapy is linked to levels of a blood protein called hepcidin. Researchers will then check if hepcidin levels are connected to how well patients can stic…